FIGURE 1 3 Immunomodulatory and anti-inflammatory effects of PYC The immunomodulatory effects of PYC have been demonstrated extensively ( in vitro study, Moreover, the toll-like receptor (TLR)-mediated immunomodulatory effects of PYC have been investigated ( In an in vitro study on microglial cells, PYC dose-dependently decreased the release of nitric oxide, tumor necrosis factor- (TNF-), interleukin (IL)-6, IL-1, ICAM-1, and perilipin 2, thereby exhibiting anti-inflammatory activity ( Ex vivo analysis of plasma from volunteers following PYC administration revealed moderate inhibition of COX-1 and COX-2 activity, indicating potential anti-inflammatory and platelet-inhibitory effects ( PYC modulated cytokine secretion by decreasing in T-helper (Th)1 cytokine levels and increasing Th2 cytokine levels and partially recovered T- and B-cell dysfunction in a mouse model ( In a murine model, PYC demonstrated neuroprotective effects following traumatic brain injury, characterized by a reduction in the proinflammatory cytokines IL-6 and TNF- ( Collectively, these reports reveal the potent anti-inflammatory and immunomodulatory effects of PYC (Figure 1), warranting further clinical trials to evaluate its therapeutic efficacy against various infections, including viral infections that induce host inflammation and immune dysregulation
The clinical significance of this faster onset remains an area of ongoing investigation
Reduced length and molecular weight were found for both enzymes, however GSH2 displayed high isoelectric point and substitutions on its active site
N-acetylcysteine improves liver function in patients with non-alcoholic fatty liver disease
Furthermore, naringenin interferes with A plaque formation by regulating amyloid precursor protein (APP) processing, reducing A production, and preventing tau hyperphosphorylation, thereby safeguarding neurons from aggregationinduced toxicity (D'Egidio et al
